Virginie Feliu

[CRCT-Oncopole @crctoncopole]

Une jeune chercheuse toulousaine soutenue pour ses travaux en cancérologie sur les cellules "super-tueuses" https://t.co/M4hGWYNeBZ via @ladepechedumidi

[CRCT-Oncopole @crctoncopole]

Congratulation at Clara Maria Scarlata from @crctoncopole who receive a best oral communication price delivered by @Integragen at the the 1st young cancer researchers congress (#YS2C_GSO)

[Virginie Feliu @FeliuVirginie]

https://t.co/58cDIq4C6m

[Virginie Feliu @FeliuVirginie]

Des chercheuses révèlent comment notre côlon lutte contre le cancer colorectal : vers des thérapies ciblées et un potentiel vaccin https://t.co/je1IRCEj0W
@ChristelDevaud @TeamT2i @IUCTOncopole @crctoncopole

[Virginie Feliu @FeliuVirginie]

Thanks EACR for your highlight (#8) @EACRnews
Highlights in Cancer Research: August 2023 https://t.co/zfS5kQvaRZ via @eacrnews

[Virginie Feliu @FeliuVirginie]

Thank you @CD_AACR for the research watch about our works, @ChristelDevaud @TeamT2i @IUCTOncopole @crctoncopole
α4β7-Positive T Cells Mediate Responses to Cancer Immunotherapy https://t.co/Z9By88T5UI

[CRCT-Oncopole @crctoncopole]

[communiqué de presse CRCT] Cancer : un mécanisme clé pour améliorer les immunothérapies identifié par une équipe toulousaine. Article publié dans le journal @ImmunityCP par l'équipe GENIM du @crctoncopole
➡️https://t.co/12nrrYXyEy

[Martinet Ludovic @MartinetLudovi2]

Happy to share with you our recent findings @CRCTOncopole @inserm
on the TCR independent role of the activating receptor CD137 on T cell exhaustion published in @ImmunityCP. #Immunotherapy #CancerResearch. https://t.co/X7R29x4ADS

[Immunology Podcast @ImmunoPodcast]

Check out this new @SciImmunology paper!

A team at @Univ_Toulouse showed how a subset of #Tcells from colon tumors improves control of liver tumors.

@FeliuVirginie @DrGomezRoca @ChristelDevaud

📰 https://t.co/f7FZnYisRZ
🎧 https://t.co/y4Z7HLawCX

[ACIR @ACIR_org]

New immune checkpoint affected by the gut #microbiome involved in lack of #immunotherapy responses in colon cancer. Read our double feature here: https://t.co/N18XGHnEJl @FeliuVirginie @ChristelDevaud @TeamT2i  @GustaveRoussy  @CarolinaAlvesC5  @derosa__lisa #CRCSM

[AYYOUB LAB @TeamT2i]

Read the interview of @ChristelDevaud & @FeliuVirginie in @ACIR_org highlighting their findings published in @SciImmunology
It's about tumor immunology & more 🤔
https://t.co/dtuo17jkdc

[Virginie Feliu @FeliuVirginie]

Congratulations @jnt_khalifa 👏

[Jonathan Khalifa 🎗️ @jnt_khalifa]

🚨🔥Hot off the press🔥 Our study on the impact of radiation to host immune structures during chemoradiation > durva in patients with st.III non small cell lung cancer is out in @FrontOncology #nsclc 🫁⚡️
🧵 1/5

https://t.co/O6tTQD5lqV

[Science Magazine @ScienceMagazine]

A new @SciImmunology study investigates how intestinal α4β7+ CD8 T cells enhance immune responses against metastatic tumors typically resistant to anti-PD-L1 immunotherapy.

📄: https://t.co/xiI2GIh0M2

[IUCT Oncopole @IUCTOncopole]

Découverte majeure à l'Oncopole de Toulouse : le côlon pourrait contrer les métastases grâce aux lymphocytes T CD8 antitumoraux, capables spontanément de contrôler la croissance de la tumeur primaire mais aussi de métastases à distance, en particulier hépatiques. ⤵️⤵️

[Devaud Christel @ChristelDevaud]

Thank you @ScienceMagazine for the fascinating perspective highlighting the central role of intestinal T cells in systemic cancer immune surveillance 👌 @FeliuVirginie @TeamT2i @SciImmunology

[Science Magazine @ScienceMagazine]

New studies in Science & @SciImmunology spotlight a group of intestinal T cells with α4β7 integrin receptors that could be targeted to prevent resistance to immune checkpoint blockade #cancer immunotherapy.

https://t.co/wJAfA6GPCp
https://t.co/Tds4vYOoSu
https://t.co/DL0sL5LzpX

[Virginie Feliu @FeliuVirginie]

Thank you for highlighting our work @SciImmunology @ChristelDevaud @TeamT2i

[Science Immunology @SciImmunology]

A new study investigates how intestinal α4β7+ CD8 T cells enhance immune responses against metastatic tumors typically resistant to anti-PD-L1 immunotherapy. @FeliuVirginie @IUCTOncopole

📄: https://t.co/7rrjtJAHV6

[CRCT-Oncopole @crctoncopole]

The power of the intestine against metastases - new article from @TeamT2i @crctoncopole published in @SciImmunology
➡️https://t.co/67e9conDdE

[CRCT-Oncopole @crctoncopole]

Le pouvoir de l’intestin contre les métastases. Nouvel article de l'équipe @TeamT2i du @crctoncopole publiée dans la revue @SciImmunology
➡️https://t.co/sr1nTIebxu